Focused engagement
Translational, Biomarker & Immunogenicity Analytics
We assess the question, technology, processing stage and specific expertise needed before proposing an analysis. Scope identifies the input data, methods, and who will perform and review the work.
Deliverables
- QC and exploratory-analysis report.
- Results tables and decision-focused visualisations.
- Reproducible scripts or pipeline and methods documentation.
- Assumptions, limitations and recommended next analyses.
When to use it
Best fit
Translational medicine, R&D and biometrics teams working with biomarkers, immunogenicity, single-cell or other omics data.
Scope
- Assess assay, molecular and clinical metadata and define an analysis-ready structure.
- Perform targeted QC, exploratory analysis and agreed biomarker or immunogenicity methods.
- Integrate molecular signals with treatment, response or clinical endpoints.
- Control multiplicity and distinguish exploratory from confirmatory claims.
Inputs
- Molecular, biomarker or immunogenicity data and data dictionary.
- Clinical metadata, endpoint definitions and treatment or visit structure.
- Assay rules, limits of quantification and sample annotation where relevant.
- Scientific questions and prior analyses.
Data handling
Real patient or confidential study data remains within the client, sponsor, CRO or contractually approved environment. The permitted data, access model and retention rules are agreed before work begins.
Do not send patient, clinical or confidential study data.
Boundaries
- Does not include wet-lab or assay validation, clinical adjudication or regulatory biomarker qualification.
- Exploratory results are not presented as validated biomarkers or confirmatory evidence.
- Enterprise infrastructure and full manuscript writing require separate scope.
Discuss this engagement
Confirm fit before sharing materials.
Describe the study situation, intended decision and deadline. We review fit and availability, agree the scope and prepare a proposal. Data access is arranged separately in an approved environment.